StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Pharma-Bio Serv

Pharma-Bio Serv has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Pharma-Bio Serv figures

See a number that looks wrong?